Wells Fargo analyst Stephen Baxter raised the firm’s price target on BrightSpring Health (BTSG) to $27 from $25 and keeps an Overweight rating on the shares. The firm is updating the model following the Q1 2025 beat and guidance increase. Wells is also increasing Pharmacy estimates and refining Provider estimates.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTSG:
- BrightSpring Health Services, Inc.: Strong Financial Performance and Strategic Growth Drive Buy Rating
- BrightSpring Health 11.23M share Block Trade priced at $20.30
- BrightSpring Health Services, Inc. Earns Buy Rating Amid Strong Financial Performance and Promising Outlook
- BrightSpring Health Services Reports Strong Q1 2025 Results
- BrightSpring Health Services Q1 Earnings Call Highlights Growth